ARGONAUT THERAPEUTICS
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.
ARGONAUT THERAPEUTICS
Social Links:
Industry:
Health Care Therapeutics
Founded:
2016-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.argonauttherapeutics.co.uk
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.57 M USD
Technology used in webpage:
Euro British Server Location
Similar Organizations
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
JW Pharmaceuticals
JW Pharmaceuticals investment in Corporate Round - Argonaut Therapeutics
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Argonaut Therapeutics
Official Site Inspections
http://www.argonauttherapeutics.co.uk
- Host name: 95.179.226.156.vultrusercontent.com
- IP address: 95.179.226.156
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1
More informations about "Argonaut Therapeutics"
Argonaut Therapeutics - Crunchbase Company Profile & Funding
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The โฆSee details»
Argonaut Therapeutics - VentureRadar
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The โฆSee details»
Argonaut Therapeutics: Contact Details and Business Profile
Argonaut Therapeutics is a Biotechnology Research, Biotechnology, and Health Care company_reader located in UK with $6 million in revenue and 5 employees. Find top โฆSee details»
Argonaut Therapeutics - PitchBook
Argonaut Therapeutics General Information Description. Developer of novel epigenetic therapies designed to offer treatment for arginine methylation in โฆSee details»
Argonaut Therapeutics - Overview, News & Similar companies
Argonaut Therapeutics contact info: Phone number: +44 1865784874 Website: www.argonauttherapeutics.co.uk What does Argonaut Therapeutics do? Argonaut โฆSee details»
Argonaut Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Argonaut Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Endocrinology and Metabolic Disease ...See details»
ARGONAUT THERAPEUTICS LIMITED - Companies House
Accounts. Next accounts made up to 31 December 2024 due by 30 September 2025 Last accounts made up to 30 June 2023See details»
Argonaut Therapeutics - EU-Startups
UK. Business Description. Argonaut Therapeutics is a spin-out from Oxford Universityโs Medical Sciences Division focusing on new cancer treatments. The technology is based on original discoveries made in Oxford that characterised โฆSee details»
Argonaut Therapeutics Ltd.:Company Profile & Technical Research ...
Argonaut Therapeutics Ltd. is a company that provides Pharmacy and Therapeutics, Arginine, Methylation and more. Argonaut Therapeutics Ltd. is headquartered in United Kingdom .See details»
Argonaut Therapeutics Limited - Company Profile - Endole
Argonaut Therapeutics Limited is an active company incorporated on 8 February 2016 with the registered office located in Oxford, Oxfordshire. Argonaut Therapeutics Limited has been โฆSee details»
Celleron Therapeutics and Argonaut Therapeutics Announce
Jan 5, 2023 For more information see https://argonauttherapeutics.co.ukAbout Oxford Science Enterprises. Oxford Science Enterprises (OSE) is an independent, billion-pound investment โฆSee details»
Argonaut Therapeutics - Company Profile - Tracxn
Argonaut Therapeutics - Developing novel inhibitors of protein arginine methyl-transferase (PRMT) to treat cancer. Raised a total funding of $2.6M over 2 rounds from 3 investors. โฆSee details»
Oxford spinout to develop cancer therapies which reprogram โฆ
Argonaut, seed funding, investment, Oxford Sciences Innovation, University of Oxford, personalised medicine, apoptosis, tumour cell deathSee details»
ARGONAUT THERAPEUTICS LIMITED - Companies House
ARGONAUT THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โฆSee details»
Celleron Therapeutics and Argonaut Therapeutics Announce โฆ
Jan 5, 2023 For more information see https://argonauttherapeutics.co.uk. About Oxford Science Enterprises. Oxford Science Enterprises (OSE) is an independent, billion-pound investment โฆSee details»
Argonaut Therapeutics - VentureRadar
Biosceptre United Kingdom Privately Held Biosceptre is a UK headquartered biotech developing next-generation cancer therapeutics utilising its proprietary target, nfP2X7.Biosceptre has โฆSee details»
Argonaut Therapeutics Announces Appointment of New Board โฆ
Oxford, UK, 21 January 2021 - Argonaut Therapeutics, a leading developer of novel cancer agents, announced the appointment of Dr Chan Hee Park to its Board of Directors, โฆSee details»
Argonaut Therapeutics Announces Successful Completion of โฆ
Oxford, UK, March 2019 - Argonaut Therapeutics, a leading developer of novel cancer therapies, announced that it has raised new capital in its latest financing round. The financing included โฆSee details»
Company Information - RocketReach
The most common Argonaut Therapeutics email format is [first].[last] (ex. [email protected]), which is being used by 75.0% of Argonaut โฆSee details»
Celleron Therapeutics and Argonaut Therapeutics Announce โฆ
For more information see https://argonauttherapeutics.co.uk About Oxford Science Enterprises . Page 3 of 3 Oxford Science Enterprises (OSE) is an independent, billion-pound investment โฆSee details»